Ken Griffin’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 5863 |
|
|
2025
Q1 | – | Sell |
-77,233
| Closed | -$45.7K | – | 5957 |
|
|
2024
Q4 | $45.7K | Buy |
77,233
+77,017
| +35,656% | +$45.5K | ﹤0.01% | 5478 |
|
|
2024
Q3 | $380 | Sell |
216
-185,081
| -100% | -$326K | ﹤0.01% | 5671 |
|
|
2024
Q2 | $254K | Buy |
185,297
+112,660
| +155% | +$154K | ﹤0.01% | 4452 |
|
|
2024
Q1 | $250K | Sell |
72,637
-508
| -0.7% | -$1.75K | ﹤0.01% | 4579 |
|
|
2023
Q4 | $180K | Sell |
73,145
-41,504
| -36% | -$102K | ﹤0.01% | 4651 |
|
|
2023
Q3 | $195K | Sell |
114,649
-17,746
| -13% | -$30.2K | ﹤0.01% | 4574 |
|
|
2023
Q2 | $397K | Sell |
132,395
-380,239
| -74% | -$1.14M | ﹤0.01% | 3845 |
|
|
2023
Q1 | $1.37M | Buy |
512,634
+446,091
| +670% | +$1.2M | ﹤0.01% | 2874 |
|
|
2022
Q4 | $549K | Sell |
66,543
-13,974
| -17% | -$115K | ﹤0.01% | 3760 |
|
|
2022
Q3 | $620K | Sell |
80,517
-98,371
| -55% | -$757K | ﹤0.01% | 3873 |
|
|
2022
Q2 | $510K | Buy |
178,888
+77,876
| +77% | +$222K | ﹤0.01% | 4112 |
|
|
2022
Q1 | $505K | Buy |
101,012
+58,636
| +138% | +$293K | ﹤0.01% | 4432 |
|
|
2021
Q4 | $832K | Buy |
+42,376
| New | +$832K | ﹤0.01% | 4031 |
|
|
2021
Q3 | – | Sell |
-152,999
| Closed | -$6.48M | – | 6380 |
|
|
2021
Q2 | $6.48M | Buy |
152,999
+69,080
| +82% | +$2.93M | ﹤0.01% | 1863 |
|
|
2021
Q1 | $4.27M | Sell |
83,919
-101,403
| -55% | -$5.15M | ﹤0.01% | 2289 |
|
|
2020
Q4 | $6.3M | Buy |
+185,322
| New | +$6.3M | ﹤0.01% | 1578 |
|